Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: Correlations between behavior and neurochemistry

Psychopharmacology

Volumn 220, Issue 3, 2012, Pages 495-508

  Murnane, Kevin Sean ^a   Perrine, Shane Alan ^d   Finton, Brendan James ^a,e   Galloway, Matthew Peter ^d   Howell, Leonard Lee ^a,b   Fantegrossi, William Edward ^c  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Amphetamine; Behavior; Dopamine; Drug abuse; HPLC; Learning and memory; Methamphetamine; Monoamine; Mouse; Neurotoxicity

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; AMPHETAMINE DERIVATIVE; CHLORAMPHETAMINE; DOPAMINE; METHAMPHETAMINE; MONOAMINE; SEROTONIN;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BRAIN LEVEL; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; EX VIVO STUDY; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; LEARNING DISORDER; MALE; MEMORY DISORDER; METABOLITE; MONOAMINERGIC SYSTEM; MOUSE; NEUROCHEMISTRY; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SEROTONINERGIC TRANSMISSION;

ADRENERGIC AGENTS; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; LINEAR MODELS; MALE; MEMORY; METHAMPHETAMINE; MICE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; P-CHLOROAMPHETAMINE; SEROTONIN; SEROTONIN AGENTS;

EID: 84858449313     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2504-0     Document Type: Article

References (51)

1. Achat-Mendes C, Ali SF, Itzhak Y (2005) Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice. Neuropsychopharmacology 30:1128-1137 (Pubitemid 40720971)
2. Achat-Mendes C, Anderson KL, Itzhak Y (2007) Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by iV-acetylcysteine but not D1 and D2 dopamine receptor agonists. Neuropsychopharmacology 32:531-541
3. Adriani W, Felici A, Sargolini F, Roullet P, Usiello A, Oliverio A, Mele A (1998) iV-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes. Exp Brain Res 123:52-59 (Pubitemid 28495296)
4. Ali SF, Newport GD, Holson RR, Slikker W Jr, Bowyer JF (1994) Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 658:33-38 (Pubitemid 24291700)
5. Barrionuevo M, Aguirre N, Del Rio JD, Lasheras B (2000) Serotonergic deficits and impaired passive-avoidance learning in rats by MDEA: a comparison with MDMA. Pharmacol Biochem Behav 65:233-240 (Pubitemid 30100268)
6. Belcher AM, Feinstein EM, O'Dell SJ, Marshall JF (2008) Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens. Neuropsychopharmacology 33:1453-1463 (Pubitemid 351521718)
7. Bolla KI, McCann UD, Ricaurte GA (1998) Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology 51:1532-1537
8. Buchert R, Obrocki J, Thomasius R, Vaterlein O, Petersen K, Jenicke L, Bohuslavizki KH, Clausen M (2001) Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET. Nucl Med Commun 22:889-897 (Pubitemid 32681627)
9. Colado MI, O'Shea E, Green AR (2004) Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology (Berl) 173:249-263 (Pubitemid 38703798)
10. Fantegrossi WE, Ciullo JR, Wakabayashi KT, De La Garza R 2nd, Traynor JR, Woods JH (2008) A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Neuroscience 151:533-543
11. Fuller RW, Hines CW, Mills J (1965) Lowering of brain serotonin level by chloramphetamines. Biochem Pharmacol 14:483-488
12. Fuller RW, Baker JC, Molloy BB (1977) Biological disposition of rigid analogs of amphetamine. J Pharm Sci 66:271-272 (Pubitemid 8040037)
13. Gibb JW, Johnson M, Stone D, Hanson GR (1990) MDMA: historical perspectives. Ann N Y Acad Sci 600:601-611, discussion 611-2
14. Gower AJ, Lamberty Y (1993) The aged mouse as a model of cognitive decline with special emphasis on studies in NMRI mice. Behav Brain Res 57:163-173 (Pubitemid 24027146)
15. Hanson KL, Luciana M (2004) Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. Psychol Med 34:229-246 (Pubitemid 38239632)
16. Hirata H, Ladenheim B, Rothman RB, Epstein C, Cadet JL (1995) Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res 677:345-347
17. Itzhak Y, Achat-Mendes CN, Ali SF, Anderson KL (2004) Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine- induced neurotoxicity in mice. Neuropharmacology 46:74-84 (Pubitemid 37494741)
18. Kalechstein AD, Newton TF, Green M (2003) Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 15:215-220 (Pubitemid 36520342)
19. Kalechstein AD, De La Garza R 2nd, Mahoney JJ 3rd, Fantegrossi WE, Newton TF (2007) MDMA use and neuro-cognition: a meta-analytic review. Psychopharmacology (Berl) 189:531-537 (Pubitemid 44791222)
20. Kish SJ, Furukawa Y, Ang L, Vorce SP, Kalasinsky KS (2000) Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user. Neurology 55:294-296 (Pubitemid 30604635)
21. Kita T, Wagner GC, Nakashima T (2003) Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci 92:178-195 (Pubitemid 36992304)
22. Krasnova IN, Hodges AB, Ladenheim B, Rhoades R, Phillip CG, Cesena A, Ivanova E, Hohmann CF, Cadet JL (2009) Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice. Neurosci Res 65:160-165
23. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet 352:1433-1437 (Pubitemid 28510877)
24. McCann UD, Peterson SC, Ricaurte GA (2007) The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users. Neuropsychopharmacology 32:1695-1706 (Pubitemid 47076382)
25. McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C (2004) Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology (Berl) 173:434-439 (Pubitemid 38703819)
26. Miller DB, O'Callaghan JP (1995) The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine. Mol Neurobiol 11:177-192
27. Myhrer T (2003) Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res Brain Res Rev 41:268-287 (Pubitemid 36355883)
28. O'Callaghan JP, Miller DB (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:741-751 (Pubitemid 24271391)
29. Obrocki J, Schmoldt A, Buchert R, Andresen B, Petersen K, Thomasius R (2002) Specific neurotoxicity of chronic use of ecstasy. Toxicol Lett 127:285-297 (Pubitemid 34615520)
30. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego
31. Pletscher A, Burkard WP, Bruderer H, Gey KF (1963) Decrease of cerebral 5-hydroxytryptamine and 5-hydroxyindolacetic acid by an arylalkylamine. Life Sci 11:828-833
32. Pletscher A, Bartholini G, Bruderer H, Burkard WP, Gey KF (1964) Chlorinated arylalkylamines affecting the cerebral metabolism of 5-hydroxytryptamine. J Pharmacol Exp Ther 145:344-350
33. Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W (2001) Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358:1864-1869 (Pubitemid 34008653)
34. Renoir T, Paizanis E, Yacoubi ME, Saurini F, Hanoun N, Melfort M, Lesch KP, Hamon M, Lanfumey L (2008) Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice. Int J Neuropsychopharmacol 11:1149-1162
35. Ricaurte GA (1989) Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis for evaluating long-term effects in humans. NIDA Res Monogr 94:306-322 (Pubitemid 20091172)
36. Saadat KS, Elliott JM, Colado MI, Green AR (2006a) The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice. J Psychopharmacol 20:264-271
37. Saadat KS, Elliott JM, Green AR, Moran PM (2006b) High-dose MDMA does not result in long-term changes in impulsivity in the rat. Psychopharmacology (Berl) 188:75-83 (Pubitemid 44268243)
38. Sanders-Bush E, Bushing JA, Sulser F (1975) Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms. J Pharmacol Exp Ther 192:33-41
39. Santucci AC, Knott PJ, Haroutunian V (1996) Excessive serotonin release, not depletion, leads to memory impairments in rats. Eur J Pharmacol 295:7-17 (Pubitemid 26027117)
40. Schmidt CJ, Levin JA, Lovenberg W (1987) In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem Pharmacol 36:747-755 (Pubitemid 17026095)
41. Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, Grant I (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17:275-297 (Pubitemid 47498174)
42. Simon SL, Dean AC, Cordova X, Monterosso JR, London ED (2010) Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. J Stud Alcohol Drugs 71:335-344
43. Steranka LR, Sanders-Bush E (1980) Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice. Eur J Pharmacol 65:439-443 (Pubitemid 10034685)
44. Steranka L, Bessent R, Sanders-Bush E (1977) Reversible and irreversible effects of p-chloroamphetamine on brain serotonin in mice. Commun Psychopharmacol 1:447-454 (Pubitemid 9001701)
45. Stone DM, Hanson GR, Gibb JW (1987) Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats. Neuropharmacology 26:1657-1661 (Pubitemid 18008368)
46. Sugimoto Y, Ohkura M, Inoue K, Yamada J (2001) Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice. Eur J Pharmacol 430:265-268 (Pubitemid 33050047)
47. Taghzouti K, Simon H, Louilot A, Herman JP, Le Moal M (1985) Behavioral study after local injection of 6-hydroxydopamine into the nucleus accumbens in the rat. Brain Res 344:9-20 (Pubitemid 15245099)
48. Timar J, Gyarmati S, Szabo A, Furst S (2003) Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives. Behav Pharmacol 14:199-206 (Pubitemid 36735152)
49. Wang X, Baumann MH, Xu H, Rothman RB (2004) 3,4-Methylenediox- ymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse 53:240-248 (Pubitemid 39045543)
50. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2:699-703 (Pubitemid 26191961)
51. Winsauer PJ, McCann UD, Yuan J, Delatte MS, Stevenson MW, Ricaurte GA, Moerschbaecher JM (2002) Effects of fenflur-amine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration. Psychopharmacology (Berl) 159:388-396 (Pubitemid 34143363)